Recon: Alzheimer’s drugmakers undeterred on accelerated approval despite Aduhelm coverage decision; Japan cancels a third of its AstraZeneca vaccine order
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy